FDA warns of brain problem with Glaxo seizure drug

(AP) -- Federal health regulators are warning doctors and patients that a seizure drug from GlaxoSmithKline can cause rare inflammation of the brain and spinal cord.

The Food and Administration says it is working with the British drugmaker Glaxo to add new warnings and labeling information to the company's drug Lamictal.

The agency said it has received reports of 40 cases of aseptic meningitis since Lamictal's approval in 1994 and last November. Thirty-five patients needed to be hospitalized, the agency said in a statement.

Aseptic meningitis is a dangerous inflammation of the brain and that can cause headache, fever, chills and vomiting. The problem can be caused by viruses, toxins and certain medications.


Explore further

FDA expands meningitis vaccine approval

©2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: FDA warns of brain problem with Glaxo seizure drug (2010, August 12) retrieved 28 November 2021 from https://medicalxpress.com/news/2010-08-fda-brain-problem-glaxo-seizure.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors